Target intelligence / Profile preview

Other miR-217 seed-matched mRNAs

Molecular classification
Messenger RNA, MicroRNA target
01

Overview

Other miR-217 seed-matched mRNAs refers to a collective group of messenger RNA (mRNA) molecules that possess sequence complementarity to the seed region (nucleotides 2-7 or 2-8) of microRNA-217 (miR-217). MicroRNAs typically regulate gene expression by binding to these seed-matched sites within the 3' untranslated regions (UTRs) of target mRNAs, leading to translational repression or mRNA degradation (PMID: 19465921). While miR-217 has well-characterized targets such as SIRT1, PTEN, and EZH2, this category represents the broader, often uncharacterized pool of transcripts that may be influenced by miR-217 levels (PMID: 20065065, PMID: 24607490). Because it describes a diverse set of transcripts rather than a single protein or specific gene, it is not a valid therapeutic target in a traditional pharmacological sense. In drug development, targeting miR-217 itself (e.g., via antagomirs or mimics) would affect this entire population of mRNAs, potentially leading to complex pleiotropic effects and safety concerns. This term is most frequently encountered in bioinformatics analyses or high-throughput screening data where specific validated targets are distinguished from the general population of predicted targets.

Other names
miR-217 target transcriptsMicroRNA-217 seed-matched sequencesmiR-217 regulated mRNAs
02

Biological functions

Post-transcriptional regulationGene silencingTranslation inhibitionmRNA degradation
03

Disease associations

CancerCardiovascular diseaseNeurodegenerative diseaseSenescence
04

Safety considerations

Off-target effectsNon-specific gene silencingPleiotropic biological effectsSystemic toxicity

Beyond the preview

Go deeper on Other miR-217 seed-matched mRNAs.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Other miR-217 seed-matched mRNAs.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call